Literature DB >> 8218598

The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity.

V Mehta1, W Hao, B M Brooks-Worrell, J P Palmer.   

Abstract

Insulin-dependent diabetes is an autoimmune disease specifically targeting the pancreatic beta cells and several observations, both experimental and clinical, suggest that the interaction of the immune system with the beta cells is in part determined by the functional state of the target cells, increased beta cell activity resulting in augmented immunologic mechanisms and vice versa for suppressed beta cell activity and decreased immune attack. In this study we investigated whether cytokine induced islet cell cytotoxicity in vitro was in part dependent on the functional state of the beta cells. Cytotoxicity of cultured rat islets was induced by IL-1 (100 pg/ml) and TNF (62.5 ng/ml) individually and in combination and beta cell activity was modulated by culturing the islets in media containing 3.3, 5.5, 11, and 20 mmol/liter glucose. Both IL-1 and TNF were cytotoxic when administered individually and the combination of IL-1 and TNF was more cytotoxic than either cytokine alone. Maximum cytotoxicity was observed at 11 mmol/liter glucose with cytotoxicity being reduced at 5.5 mmol/liter glucose and further reduced at 3.3 mmol/liter glucose. Interestingly, the degree of cytotoxicity was lower in 20 mmol/liter glucose compared to 11 mmol/liter. These results firmly establish that islet cytotoxicity of IL-1 and TNF is highly dependent on the functional state of the beta cells. This suggests that during the IDDM disease process as some beta cells are destroyed, the compensatory increased activity of the remaining beta cells may increase their susceptibility to cytokine attack. Furthermore, our observations provide rational support for the use of beta cell rest as intervention therapy for IDDM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218598

Source DB:  PubMed          Journal:  Lymphokine Cytokine Res        ISSN: 1056-5477


  7 in total

1.  Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse.

Authors:  J P Palmer
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

Authors:  Tandy Aye; Jen Block; Bruce Buckingham
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

3.  The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance.

Authors:  Wei Hao; Carla J Greenbaum; Jeffrey P Krischer; David Cuthbertson; Jennifer B Marks; Jerry P Palmer
Journal:  Diabetes Care       Date:  2015-02-26       Impact factor: 19.112

4.  Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells.

Authors:  Michael C Lawrence; Bashoo Naziruddin; Marlon F Levy; Andrew Jackson; Kathleen McGlynn
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Impact of metabolic activity of beta cells on cytokine-induced damage and recovery of rat pancreatic islets.

Authors:  A Dunger; D Schröder; P Augstein; T Witstruck; G Wachlin; L Vogt; B Ziegler; S Schmidt
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

6.  Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1beta mediated suppression--possible involvement of the mitochondrial membrane potential.

Authors:  M Kullin; Z Li; J Bondo Hansen; N Welsh; F A Karlsson; S Sandler
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

7.  Fibroblasts from type 1 diabetics exhibit enhanced Ca(2+) mobilization after TNF or fat exposure.

Authors:  Nicholas R Husni; Albert R Jones; Amber L Simmons; Barbara E Corkey
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.